Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms

• मुख्य लेखकों: Melpomeni Fani (लेखक), Petra Kolenc Peitl (लेखक), Irina Velikyan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2017-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract: Nuclear medicine plays a pivotal role in the management of patients affected by neuroendocrine neoplasms (NENs). Radiolabeled somatostatin receptor analogs are by far the most advanced radiopharmaceuticals for diagnosis and therapy (radiotheranostics) of NENs. Their clinical success emerge...